University of Hyderabad Researchers Develop Nanomedicine for Malaria Treatment
- UoH researcher Dr. Pradip Paik and his team of Ph.D. scholars developed the new formulation of porous polymer capsules for treating Malaria.
- The research turned out to be successful with outstanding anti-malarial activity.
Associate Professorat School of Engineering Sciences and Technology, theUniversity of Hyderabad (UoH)and his team achieved a significant milestone byinventing polymer nanomedicinefor the treatment ofMalaria.Dr. Pradip Paikand his team have been working over the past few months to come up with nanomedicine for treating one of the dangerous diseases Malaria. At present, Dr. Pradip is on assignment in the School of Biomedical Engineering ofIIT BHU.
The significant nanomedicine is highly effective in regulating thePlasmodium falciparum infection. Biodegradable porous polymeric nanocapsules have been used for preparing nanomedicine. It is the most capable and frequently used medicine for treating Malaria. Plasmodium falciparum is the most deadly parasite among the four parasite species. In the current perspective, new drug delivery systems and anti-malarial drugs are urgently necessary.
Also Read:IIIT Hyderabad Students Bag Internship Opportunity at Berkeley Lab
According toWHO (World Health Organisation)report, Malaria is the most life-threatening ailments in humans with 212 million cases being registered every year.
The innovation made by Dr. Pradip and his team is completely against the existing backdrop. The team has developed the new formulation ofporous polymer capsules. The team has found outstanding anti-malarial activity through their innovation. ‘Time-temperature clock’ module is equipped with the new drug delivery system. Through the new drug system, the dosses for the treatment of Malaria can be precisely tuned. Dr. Pradip pointed that the new formulation is effective in killing the Plasmodium falciparum infection inRed Blood Cells (RBCs).
Also Read:IIT Hyderabad Inaugurates 24thNational Conference on Communications (NCC)
The team of Dr. Pradip comprises of Ph.D. scholars Himadri Medhi, Suresh Kumar Chalapareddy, Niranjan Suthram and Somedutta Maity.